Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (36)
Xiang Li & Li Wang. (2023) Highland barley attenuates high fat and cholesterol diet induced hyperlipidemia in mice revealed by 16S rRNA gene sequencing and untargeted metabolomics. Life Sciences 334, pages 122142.
Crossref
Crossref
Federica Fogacci, Valentina Di Micoli, Ashot Avagimyan, Marina Giovannini, Egidio Imbalzano & Arrigo F. G. Cicero. (2023) Assessment of Apolipoprotein(a) Isoform Size Using Phenotypic and Genotypic Methods. International Journal of Molecular Sciences 24:18, pages 13886.
Crossref
Crossref
Yuesong Pan, Xueli Cai, Jing Jing, Suying Wang, Xia Meng, Lerong Mei, Yingying Yang, Aoming Jin, Yao DongXiao, Shan Li, Hao Li, Tiemin Wei, Yongjun Wang & Yilong Wang. (2022) Differential associations of lipoprotein(a) level with cerebral large artery and small vessel diseases. Stroke and Vascular Neurology 7:6, pages 534-540.
Crossref
Crossref
Don P. Wilson, Terry A. Jacobson, Peter H. Jones, Marlys L. Koschinsky, Catherine J. McNeal, Børge G. Nordestgaard & Carl E. Orringer. (2022) Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association. Journal of Clinical Lipidology 16:5, pages e77-e95.
Crossref
Crossref
Serban Maierean, Richard Webb, Maciej Banach & Mohsen Mazidi. (2022) The role of inflammation and the possibilities of inflammation reduction to prevent cardiovascular events. European Heart Journal Open 2:4.
Crossref
Crossref
Tomoaki Okada, Toru Miyoshi, Masayuki Doi, Kazumasa Nosaka, Ryu Tsushima, Satoko Ugawa, Wataru Takagi, Masahiro Sogo, Masahiko Takahashi & Hiroshi Ito. (2022) Effect of Early Initiation of Evolocumab on Lipoprotein(a) in Patients with Acute Myocardial Infarction: Sub-Analysis of a Randomized Controlled Trial. Journal of Cardiovascular Development and Disease 9:5, pages 153.
Crossref
Crossref
Giuseppe Lippi, Ivan Szergyuk, Maria Helena Santos de Oliveira, Stefanie W. Benoit, Justin L. Benoit, Emmanuel J. Favaloro & Brandon Michael Henry. (2021) The role of lipoprotein(a) in coronavirus disease 2019 (COVID-19) with relation to development of severe acute kidney injury. Journal of Thrombosis and Thrombolysis 53:3, pages 581-585.
Crossref
Crossref
Dianzhi Hou, Fang Liu, Xin Ren, Qun Shen & Sumei Zhou. (2021) Protective mechanism of mung bean coat against hyperlipidemia in mice fed with a high-fat diet: insight from hepatic transcriptome analysis. Food & Function 12:24, pages 12434-12447.
Crossref
Crossref
Peter E. Penson & Maciej Banach. (2020) The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia. Current Atherosclerosis Reports 22:11.
Crossref
Crossref
Giuseppe Lippi & Giovanni Targher. (2020) Further advices on measuring lipoprotein(a) for reducing the residual cardiovascular risk on statin therapy. Clinical Chemistry and Laboratory Medicine (CCLM) 58:8, pages e144-e147.
Crossref
Crossref
Giuseppe Lippi, Emmanuel J. Favaloro & Fabian Sanchis-Gomar. (2020) Antisense lipoprotein[a] therapy: State-of-the-art and future perspectives. European Journal of Internal Medicine 76, pages 8-13.
Crossref
Crossref
Jun Watanabe, Masato Hamasaki & Kazuhiko Kotani . (2020) Risk of cardiovascular disease with lipoprotein(a) in familial hypercholesterolemia: a review. Archives of Medical Science – Atherosclerotic Diseases 5:1, pages 148-152.
Crossref
Crossref
Ronald S. Swerdloff & Robert E. Dudley. (2020) A new oral testosterone undecanoate therapy comes of age for the treatment of hypogonadal men. Therapeutic Advances in Urology 12, pages 175628722093723.
Crossref
Crossref
Maciej Banach & Peter E Penson. (2020) Statins and Lp(a): do not make perfect the enemy of excellent. European Heart Journal 41:1, pages 190-191.
Crossref
Crossref
Yuesong PanHao LiYilong WangXia MengYongjun Wang. (2019) Causal Effect of Lp(a) [Lipoprotein(a)] Level on Ischemic Stroke and Alzheimer Disease. Stroke 50:12, pages 3532-3539.
Crossref
Crossref
Kazuhiko Kotani, Shingo Yamada, Hirokazu Takahashi, Yoshitaka Iwazu & Toshiyuki Yamada. (2019) The Ratio of Oxidized Lipoprotein(a) to Native Lipoprotein(a) and the Endothelial Function in Patients with Type 2 Diabetes Mellitus. International Journal of Molecular Sciences 20:19, pages 4909.
Crossref
Crossref
Krzysztof Dyrbuś, Mariusz Gąsior, Piotr Desperak, Tadeusz Osadnik, Jolanta Nowak & Maciej Banach. (2019) The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: Results from the TERCET registry with 19,781 individuals. Atherosclerosis 288, pages 33-41.
Crossref
Crossref
Amir Abbas Momtazi‐Borojeni, Niki Katsiki, Matteo Pirro, Maciej Banach, Khalid Al Rasadi & Amirhossein Sahebkar. (2019) Dietary natural products as emerging lipoprotein(a)‐lowering agents. Journal of Cellular Physiology 234:8, pages 12581-12594.
Crossref
Crossref
Kamil F. Faridi, Renato Quispe, Seth S. Martin, Aditya D. Hendrani, Parag H. Joshi, Eliot A. Brinton, Daniel E. Cruz, Maciej Banach, Peter P. Toth, Krishnaji Kulkarni & Steven R. Jones. (2019) Comparing different assessments of remnant lipoprotein cholesterol: The very large database of lipids. Journal of Clinical Lipidology 13:4, pages 634-644.
Crossref
Crossref
Don P. Wilson, Terry A. Jacobson, Peter H. Jones, Marlys L. Koschinsky, Catherine J. McNeal, Børge G. Nordestgaard & Carl E. Orringer. (2019) Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association. Journal of Clinical Lipidology 13:3, pages 374-392.
Crossref
Crossref
Maciej Banach & Peter E Penson. (2019) What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcome trials: ODYSSEY and FOURIER?. Cardiovascular Research 115:3, pages e26-e31.
Crossref
Crossref
Shan Li, Junhui Li, Guizhu Mao, Yaqin Hu, Xingqian Ye, Ding Tian, Robert J. Linhardt & Shiguo Chen. (2018) Fucosylated chondroitin sulfate oligosaccharides from Isostichopus badionotus regulates lipid disorder in C57BL/6 mice fed a high-fat diet. Carbohydrate Polymers 201, pages 634-642.
Crossref
Crossref
Peter E Penson, D Leann Long, George Howard, Peter P Toth, Paul Muntner, Virginia J Howard, Monica M Safford, Steven R Jones, Seth S Martin, Mohsen Mazidi, Alberico L Catapano & Maciej Banach. (2018) Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study. European Heart Journal 39:40, pages 3641-3653.
Crossref
Crossref
Weimin Ren & Xiaobo Yang. (2018) Pathophysiology of Long Non-coding RNAs in Ischemic Stroke. Frontiers in Molecular Neuroscience 11.
Crossref
Crossref
Kamal Awad, Dimitri P. Mikhailidis, Niki Katsiki, Paul Muntner & Maciej Banach. (2018) Effect of Ezetimibe Monotherapy on Plasma Lipoprotein(a) Concentrations in Patients with Primary Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Drugs 78:4, pages 453-462.
Crossref
Crossref
Loukianos S. Rallidis, George Pavlakis, Alexandra Foscolou, Christos Kotakos, Andreas Katsimardos, Alexandros Drosatos, Maria Zolindaki & Demosthenes B. Panagiotakos. (2018) High levels of lipoprotein (a) and premature acute coronary syndrome. Atherosclerosis 269, pages 29-34.
Crossref
Crossref
T. V. Baidina, M. A. Danilova & V. Yu. Mishlanov. (2018) Lipoprotein (a) in patients with carotid atherosclerosis. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 118:8, pages 82.
Crossref
Crossref
Luis E. Simental-Mendía, Antonio M. GottoJr.Jr., Stephen L. Atkin, Maciej Banach, Matteo Pirro & Amirhossein Sahebkar. (2018) Effect of soy isoflavone supplementation on plasma lipoprotein(a) concentrations: A meta-analysis. Journal of Clinical Lipidology 12:1, pages 16-24.
Crossref
Crossref
Paolo Emilio Puddu, Paolo Piras, Daan Kromhout, Hanna Tolonen, Anthony Kafatos & Alessandro Menotti. (2017) Re-calibration of coronary risk prediction: an example of the Seven Countries Study. Scientific Reports 7:1.
Crossref
Crossref
Marta Broto, Roger Galve & M.-Pilar Marco. (2017) Sandwich NP-based biobarcode assay for quantification C-reactive protein in plasma samples. Analytica Chimica Acta 992, pages 112-118.
Crossref
Crossref
Amirhossein Sahebkar, Maria-Corina Serban, Peter Penson, Camelia Gurban, Sorin Ursoniu, Peter P. Toth, Steven R. Jones, Giuseppe Lippi, Kazuhiko Kotani, Karam Kostner, Manfredi Rizzo, Jacek Rysz & Maciej Banach. (2017) The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-Analysis. Drugs 77:11, pages 1187-1197.
Crossref
Crossref
Shan Li, Junhui Li, Zijian Zhi, Yaqin Hu, Jian Ge, Xingqian Ye, Ding Tian, Robert J. Linhardt & Shiguo Chen. (2017) 4-O-Sulfation in sea cucumber fucodians contribute to reversing dyslipidiaemia caused by HFD. International Journal of Biological Macromolecules 99, pages 96-104.
Crossref
Crossref
Martina Rangl, Luca Rima, Jessica Klement, Atsushi Miyagi, Sandro Keller & Simon Scheuring. (2017) Real-time Visualization of Phospholipid Degradation by Outer Membrane Phospholipase A using High-Speed Atomic Force Microscopy. Journal of Molecular Biology 429:7, pages 977-986.
Crossref
Crossref
Shaoli Zhou, Qianqian Zhu, Xiang Li, Chaojin Chen, Jiping Liu, Yuping Ye, Ying Ruan & Ziqing Hei. (2017) Asymmetric dimethylarginine and all-cause mortality: a systematic review and meta-analysis. Scientific Reports 7:1.
Crossref
Crossref
M. Florentin, M. S. Elisaf, C. V. Rizos, V. Nikolaou, E. Bilianou, C. Pitsavos & E. N. Liberopoulos. (2016) l-Carnitine/Simvastatin Reduces Lipoprotein (a) Levels Compared with Simvastatin Monotherapy: A Randomized Double-Blind Placebo-Controlled Study. Lipids 52:1, pages 1-9.
Crossref
Crossref
Qin Yang, Yong-Ming He, Dong-Ping Cai, Xiang-Jun Yang & Hai-Feng Xu. (2016) Risk burdens of modifiable risk factors incorporating lipoprotein (a) and low serum albumin concentrations for first incident acute myocardial infarction. Scientific Reports 6:1.
Crossref
Crossref